Relationship between mitochondrial DNA A10398G polymorphism and Parkinson's disease: a meta-analysis
Authors:
Open Access
- 15 September 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 78023-78030
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Feifei Hua1, Xiaona Zhang1, Binghui Hou1, Li Xue2 and Anmu Xie1 1Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China 2Department of Rehabilitation, The Affiliated Hospital of Qingdao University, Qingdao, China Correspondence to: Anmu Xie, email: xieanmu@163.com Keywords: Parkinson’s disease, Mitochondrial DNA, gene polymorphism, meta-analysis Received: July 21, 2017 Accepted: August 29, 2017 Published: September 15, 2017 ABSTRACT Many studies have researched the mitochondrial DNA (mtDNA) A10398G in Parkinson’s disease (PD) to determine the association between mtDNA A10398G and PD, but the results of their research were not consistent. Therefore, we performed a meta-analysis to demonstrate the connection between mtDNA A10398G and the susceptibility of PD. We searched PubMed, Web of Science, Springer Link, EMBASE and EBSCO databases up to identify relevant studies. Through strict inclusion and exclusion criteria, at last, 9 studies (total 3381 cases and 2810 controls) were included in our meta-analysis. We used the STATA 12.0 statistics software to calculate the pooled odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the genetic association between mtDNA A10398G and the risk of PD. We performed subgroup analysis to clarify the possible roles of the mtDNA A10398G polymorphism in the aetiology of PD in different ethnicities. Our meta-analysis indicates that although there was no significant association between mtDNA A10398G and PD in the Asian population (G vs. A: OR = 1.090, 95% CI = 0.939–1.284, P = 0.242), in the Caucasian population the G allele of mtDNA A10398G mutations may be a potential protective factor of PD (G vs. A: OR = 0.699, 95% CI = 0.546–0.895, P = 0.005). Further well-designed studies with larger samples are needed to validate these results.Keywords
This publication has 35 references indexed in Scilit:
- Brain Iron Metabolism Dysfunction in Parkinson’s DiseaseMolecular Neurobiology, 2016
- Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's diseaseBMC Medical Genetics, 2011
- Mitochondrial damage controlNature, 2010
- No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genesNeuroscience Letters, 2007
- Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish populationJournal of the Neurological Sciences, 2005
- Heterogeneity testing in meta‐analysis of genome searchesGenetic Epidemiology, 2004
- Mitochondrial DNA polymorphisms as risk factors for Parkinson?s disease and Parkinson?s disease dementiaHuman Genetics, 2004
- Mitochondrial involvement in Parkinson's diseaseNeurochemistry International, 2002
- Role of Mitochondria in Parkinson DiseaseBiological Chemistry, 1999
- Mitochondrial oxidative phosphorylation defects in parkinson's diseaseAnnals of Neurology, 1991